Liu LS - Search Results

1

Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study.

Pan GH, Chen Z, Xu L, Zhu JH, Xiang P, Ma JJ, Peng YW, Li GH, Chen XY, Fang JL, Guo YH, Zhang L, Liu LS. Pan GH, et al. Among authors: liu ls. Oncotarget. 2016 Mar 15;7(11):12089-101. doi: 10.18632/oncotarget.7725. Oncotarget. 2016. PMID: 26933811 Free PMC article. Clinical Trial.

2

[Characteristics of neoplasm occurrence of renal allograft recipients and their prognosis].

Wang CX, Liu LS, Chen LZ, Wu PG, Xie D, Fei JG, Qiu J, Deng SX, Zheng KL, Ji YL, Zhu LY, Shen QR, He XS. Wang CX, et al. Among authors: liu ls. Ai Zheng. 2005 Feb;24(2):222-5. Ai Zheng. 2005. PMID: 15694039 Chinese.

3

[Living-related kidney transplantation: report of 175 cases].

Deng SX, Liu LS, Wang CX, Chen LZ, Fei JG, Qiu J, Li J, Chen GD. Deng SX, et al. Among authors: liu ls. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Sep;29(9):1878-81. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19778816 Chinese.

4

Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study.

Peng Y, Ke M, Xu L, Liu L, Chen X, Xia W, Li X, Chen Z, Ma J, Liao D, Li G, Fang J, Pan G, Xiang AP. Peng Y, et al. Transplantation. 2013 Jan 15;95(1):161-8. doi: 10.1097/TP.0b013e3182754c53. Transplantation. 2013. PMID: 23263506

5

Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.

Chen SY, Li JL, Meng FH, Wang XD, Liu T, Li J, Liu LS, Fu Q, Huang M, Wang CX. Chen SY, et al. Among authors: liu ls, liu t. Clin Transplant. 2013 May-Jun;27(3):E272-81. doi: 10.1111/ctr.12101. Epub 2013 Feb 24. Clin Transplant. 2013. PMID: 23432535 Clinical Trial.

6

Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.

Peng Y, Chen X, Liu Q, Xu D, Zheng H, Liu L, Liu Q, Liu M, Fan Z, Sun J, Li X, Zou R, Xiang AP. Peng Y, et al. Stem Cells Transl Med. 2014 Sep;3(9):1023-31. doi: 10.5966/sctm.2014-0001. Epub 2014 Jul 10. Stem Cells Transl Med. 2014. PMID: 25015640 Free PMC article. Clinical Trial.

7

Nestin(+) kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury.

Jiang MH, Li G, Liu J, Liu L, Wu B, Huang W, He W, Deng C, Wang D, Li C, Lahn BT, Shi C, Xiang AP. Jiang MH, et al. Biomaterials. 2015 May;50:56-66. doi: 10.1016/j.biomaterials.2015.01.029. Epub 2015 Feb 14. Biomaterials. 2015. PMID: 25736496

8

Steroid Avoidance or Withdrawal Regimens in Paediatric Kidney Transplantation: A Meta-Analysis of Randomised Controlled Trials.

Zhang H, Zheng Y, Liu L, Fu Q, Li J, Huang Q, Liu H, Deng R, Wang C. Zhang H, et al. PLoS One. 2016 Mar 18;11(3):e0146523. doi: 10.1371/journal.pone.0146523. eCollection 2016. PLoS One. 2016. PMID: 26991793 Free PMC article.

9

En bloc kidney transplantation from infant donors younger than 10 months into pediatric recipients.

Wang HY, Li J, Liu LS, Deng RH, Fu Q, Ko DS, Zhang HX, Deng SX, Wang CX. Wang HY, et al. Among authors: liu ls. Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12845. Epub 2017 Jan 1. Pediatr Transplant. 2017. PMID: 28042690

10

Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study.

Li J, Chen S, Qin X, Fu Q, Bi H, Zhang Y, Wang X, Liu L, Wang C, Huang M. Li J, et al. Drug Metab Dispos. 2017 Nov;45(11):1114-1119. doi: 10.1124/dmd.117.076737. Epub 2017 Sep 1. Drug Metab Dispos. 2017. PMID: 28864749 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters